ImagineHealth Announces Strategic Collaboration with Neurolink AI and Heuron Global

ImagineHealth Co., Ltd. is pleased to announce a strategic collaboration with Neurolink AI Co. Ltd. und Heuron Global Co. Ltd. to bring advanced brain health diagnostics to Thailand’s leading private hospitals and clinics.

As part of this collaboration, ImagineHealth will focus on introducing Heuron’s AI-powered neuroimaging solutions to providers with a strong emphasis on prevention, longevity, and measurable health outcomes.

At the center of this initiative is “Heuron AI,” a globally recognized innovation in brain and neurological diagnostic imaging. The technology enables physicians to identify early signs of neurological conditions, including Alzheimer’s and Parkinson’s disease, as well as stroke-related risks, with a level of precision and speed that supports proactive and preventive care.

Advancing Brain Health in the Longevity Era

As the longevity sector continues to evolve, the focus is shifting from reactive treatment to early detection and long-term health management.

Brain health is becoming a central concern for patients and clients alike, particularly as awareness of cognitive decline increases globally. However, many providers still lack the tools to quantify brain aging, track treatment outcomes, and engage patients in a meaningful, ongoing way.

Through this collaboration, ImagineHealth aims to address exactly this gap.

Healthcare providers will be able to:

• Quantify Brain Age using advanced MRI-based AI analysis
• Detect early indicators of neurodegenerative diseases such as Alzheimer’s and Parkinson’s
• Track changes over time to measure treatment effectiveness
• Strengthen patient communication through clear, visualized reporting

A New Standard for Preventive and Longevity Care

The integration of Heuron AI into clinical workflows represents an important step toward more structured and measurable longevity medicine.

By transforming MRI data into actionable insights, providers can move beyond one-time diagnostics and build long-term engagement with their patients. This aligns closely with the broader shift toward preventive healthcare and personalized longevity programs.

Henning Kalwa, CEO of ImagineHealth, commented:

“Many people today are concerned not just about how long they live, but how well their brain is aging. By combining a standard brain MRI with Heuron’s proprietary AI-based technology, we can deliver meaningful insights and create awareness at a much earlier stage.”

He added:

“For providers, this is not only a clinical advancement, but also a structural one. It allows them to quantify brain health, measure treatment success, and build long-term patient relationships based on data rather than assumption.”

Strengthening Thailand’s Position in Medical and Wellness Tourism

This collaboration further reinforces Thailand’s position as a leading destination for medical and wellness tourism.

By integrating advanced AI-driven diagnostics into private healthcare settings, Thailand can continue to attract international patients seeking high-quality, forward-looking solutions in longevity and preventive medicine.

The partnership between Neurolink AI, Heuron Global, and ImagineHealth reflects a shared commitment to bringing global innovation into practical, real-world healthcare environments.

Blick nach vorn

ImagineHealth will begin engaging with selected private hospitals and clinics in Thailand to introduce Heuron AI and explore implementation opportunities.

As the demand for measurable, prevention-focused healthcare continues to grow, this collaboration marks an important step toward building a more structured and data-driven longevity ecosystem.